Vancomycin concentrations during cardiopulmonary bypass in pediatric cardiac surgery: a prospective study

被引:1
|
作者
Ferrari, Fiorenza [1 ]
Benegni, Simona [2 ]
Marinari, Eleonora [2 ]
Haiberger, Roberta [2 ]
Garisto, Cristiana [2 ]
Rizza, Alessandra [2 ]
Giorni, Chiara [2 ]
Quattrone, Maria Giovanna [1 ]
Arpicco, Silvia [3 ]
Muntoni, Elisabetta [3 ]
Milla, Paola [3 ]
Ricci, Zaccaria [4 ,5 ]
机构
[1] IRCCS Fdn Policlin San Matteo, Intens Care Unit, Pavia, Italy
[2] IRCCS, Bambino Gesu Childrens Hosp, Pediat Cardiac Intens Care Unit, Dept Cardiol & Cardiac Surg, Rome, Italy
[3] Univ Turin, Dept Drug Sci & Technol, Turin, Italy
[4] Azienda Osped Univ Meyer, Florence, Italy
[5] Univ Firenze, Florence, Italy
来源
PERFUSION-UK | 2022年 / 37卷 / 06期
关键词
vancomycin; pediatric cardiac surgery; cardiopulmonary bypass; pharmacokinetics; pharmacodynamics; EXTRACORPOREAL MEMBRANE-OXYGENATION; POPULATION PHARMACOKINETICS; ANTIBIOTIC-PROPHYLAXIS; INFECTIONS; GUIDELINE; OUTCOMES; SOCIETY; DRUGS;
D O I
10.1177/02676591211006828
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Few data are available regarding intraoperative plasma concentrations of vancomycin administered as prophylaxis in pediatric cardiac surgery. The aims of this study were to investigate during pediatric cardiac surgery with cardiopulmonary bypass(CPB) the attainment of the area-under-the-curve of the vancomycin serum concentrations versus time over surgery to minimum inhibitory concentration ratio(AUC(intra)/MIC) of 400 (mg x h)/l and/or a target concentration of 15-20 mg/l. Methods: In a prospective study, 40 patients divided into four subgroups (neonates, infants, children <10 years-old, > 10 years-old) undergoing cardiac surgery with cardiopulmonary bypass (CPB) were enrolled. A slow vancomycin bolus of 20 mg/kg, up to a maximum dose of 1000 mg was administered before skin incision and a further dose of 10 mg/kg (up to 500 mg) at CPB start. Vancomycin samples were collected intraoperatively at four time points. Results: The median (interquartile range) age was 241.5 days (47-3898) and the median weight was 7.1 kg (3.1-37). The median AUC(intra)/MIC was 254.73 (165.89-508.06). In 11 patients the AUC(intra)/MIC target was not reached. Neonates displayed the lowest AUC(intra)/MIC values, and these were significantly lower than those of children > 10 years old (p = 0.02). Vancomycin concentrations were above the maximal target of 20 mg/l in 82.5% and 80% of patients at surgery and CPB start, respectively. At CPB and surgery end, 42.5% of patients showed vancomycin concentrations above 20 mg/l and 42.5% below 15 mg/l. Patients > 10 years old showed the highest peak values whereas neonates were those with the lowest troughs. AUC(intra)/MIC correlated with age(r:0.36, p = 0.02), weight(r:0.35, p = 0.03), intraoperative protein value(r:0.40, p = 0.01), CPB priming volume/kg(r:-0.33, p = 0.04), CPB duration(r:0.36, p = 0.02) and vancomycin troughs(r:0.35, p = 0.04). Conclusions: An AUC(intra)/MIC > 400 target was not reached in one-quarter of children undergoing heart surgery. Vancomycin peaked before the start of surgery and neonates were those with the lowest troughs. Vancomycin concentrations are affected by CPB hemodilution and by patients' age and weight.
引用
收藏
页码:553 / 561
页数:9
相关论文
共 50 条
  • [21] Sanguineous cardiopulmonary bypass prime accelerates the inflammatory response during pediatric cardiac surgery
    Bierer, Joel
    Stanzel, Roger
    Henderson, Mark
    Sapp, John
    Andreou, Pantelis
    Marshall, Jean S.
    Horne, David
    PERFUSION-UK, 2024,
  • [22] Interval changes in ROTEM values during cardiopulmonary bypass in pediatric cardiac surgery patients
    Christopher F. Tirotta
    Richard G. Lagueruela
    Daria Salyakina
    Weize Wang
    Thomas Taylor
    Jorge Ojito
    Kathleen Kubes
    Hyunsoo Lim
    Robert Hannan
    Redmond Burke
    Journal of Cardiothoracic Surgery, 14
  • [23] A Table Mounted Cardiopulmonary Bypass System for Pediatric Cardiac Surgery
    Costa, Ana Claudia B. A.
    Parham, Darren R.
    Ashley, Justin E.
    Nguyen, Khanh H.
    ANNALS OF THORACIC SURGERY, 2018, 106 (03): : E163 - E165
  • [24] Trends and Updates on Cardiopulmonary Bypass Setup in Pediatric Cardiac Surgery
    Medikonda, Ravi
    Ong, Chin Siang
    Wadia, Rajeev
    Goswami, Dheeraj
    Schwartz, Jamie
    Wolff, Larry
    Hibino, Narutoshi
    Vricella, Luca
    Daniel Nyhan
    Barodka, Viachaslau
    Steppan, Jochen
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2019, 33 (10) : 2804 - 2813
  • [25] Modified ultrafiltration after cardiopulmonary bypass in pediatric cardiac surgery
    Draaisma, AM
    Hazekamp, MG
    Frank, M
    Anes, N
    Schoof, PH
    Huysmans, HA
    ANNALS OF THORACIC SURGERY, 1997, 64 (02): : 521 - 525
  • [26] VANCOMYCIN DISPOSITION DURING CARDIOPULMONARY BYPASS
    KLAMERUS, KJ
    RODVOLD, KA
    LEVITSKY, S
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (06): : 466 - 467
  • [27] ADMINISTRATION OF VANCOMYCIN DURING CARDIOPULMONARY BYPASS
    BARAKA, A
    TAHA, S
    BIJJANI, A
    ARAB, W
    MESHEFEDJIAN, G
    ANAESTHESIA, 1992, 47 (12) : 1086 - 1087
  • [28] Exploring the effects of hemodialyzers on clinical outcomes in pediatric cardiac surgery during cardiopulmonary bypass: a retrospective cohort study
    Abdelazim, Ahmed M.
    Amer, Akram M.
    Elsobky, Yasmin
    Shelbaya, Khaled
    Fadaly, Ahmed S.
    CARDIOTHORACIC SURGEON, 2025, 33 (01):
  • [29] A prospective cohort study of dynamic cell-free DNA elevation during cardiac surgery with cardiopulmonary bypass
    Ishay, Shlomo Yaron
    Abu-Tailakh, Muhammad
    Raichel, Lior
    Hershenhoren, Tal F.
    Matsa, Menahem
    Lev-Ran, Oren
    Gideon, Sahar
    Douvdevani, Amos
    PLOS ONE, 2022, 17 (10):
  • [30] Neuroprotective Strategies during Cardiac Surgery with Cardiopulmonary Bypass
    Salameh, Aida
    Dhein, Stefan
    Dahnert, Ingo
    Klein, Norbert
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (11)